FIELD: medical engineering.
SUBSTANCE: system is selectable from a group having implant, intrauterine system, intracervical system or intravaginal system having core and membrane. The core has at least one therapeutic agent and at least the first and the second part. At least one separating membrane is available between the first and the second part. The core and membrane are manufactured from elastomer composition like poly(dimethylsiloxane), siloxane -based elastomer having 3,3,3-trifluoropropyl groups attached to Si atoms of siloxane links, or elastomer composition having poly(alkyleneoxide) groups available as alcoxi- terminal engrafting or units connected to polysiloxane links with carbonic silicon bonds, or as mixture of given forms and combination at least of two from them. The core and membrane have identical or different elastomer compositions.
EFFECT: enabled at least two agents release at the same time at preset rates; excluded harmful action in system damage cases.
22 cl, 14 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING A DRUG DELIVERY DEVICE AND A DRUG DELIVERY DEVICE MADE BY SAID METHOD | 2016 |
|
RU2732822C2 |
OTORHINOLOGICAL DELIVERING DEVICE | 2004 |
|
RU2334525C2 |
NOVEL MEMBRANE OR MATRIX FOR ADJUSTABLE PENETRATION OF MEDICINAL DRUGS | 1999 |
|
RU2231531C2 |
DELIVERY SYSTEM | 2005 |
|
RU2412693C2 |
DEVICE FOR DELIVERING MEDICAMENT, MAINLY FOR DELIVERING ANDROGENS | 1999 |
|
RU2226388C2 |
DEVICE FOR DELIVERING MEDICAMENT, MAINLY FOR DELIVERING PROGESTINS AND ESTROGENS | 1999 |
|
RU2226387C2 |
DEVICE FOR DELIVERING MEDICINAL AGENTS OF ANTI-PROGESTINE ACTIVITY | 2000 |
|
RU2228170C2 |
USE OF TOCOPHEROL | 2008 |
|
RU2461584C2 |
DELIVERY SYSTEM AND METHOD FOR PRODUCING THE SYSTEM | 2003 |
|
RU2297810C2 |
DRUG PENETRATION RATE-CONTROLLING MEMBRANE OR MATRIX | 1999 |
|
RU2201794C2 |
Authors
Dates
2007-07-20—Published
2002-08-27—Filed